Immutep Limited (PRRUF)
OTCMKTS · Delayed Price · Currency is USD
0.1940
-0.0180 (-8.49%)
At close: May 29, 2025
Immutep Market Cap
Immutep has a market cap or net worth of $243.20 million as of August 22, 2025. Its market cap has decreased by -19.42% in one year.
Market Cap
243.20M
Enterprise Value
140.82M
Revenue
3.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 2.90M to 243.20M, an increase of 8,293.64%. That is a compound annual growth rate of 16.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 243.20M | -26.03% |
| Dec 31, 2024 | 328.79M | 17.60% |
| Dec 29, 2023 | 279.58M | 70.12% |
| Dec 30, 2022 | 164.35M | -45.99% |
| Dec 31, 2021 | 304.31M | 46.51% |
| Dec 31, 2020 | 207.70M | 192.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |